Axovant Gene Therapies Ltd (AXGT)

[tootalljones]

The company obviously worth owning in this sector is Anavex. symbol: Avxl. It released partial data on july 22.2015 from its open label phase 2A trial that showed spectacular efficacy. More data which people in the know suggest will be confirmatory, is being released at a science conference on November 7th. Less than two weeks ago, the top expert (arguably) in Europe who has 400 published articles, and has written 8 books on Alzheimers, signed on with the science team at Anavex. He wanted to get on board and surely the company shared with him its most recent data. he wanted in.